Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Severe adverse events MCID: 50 per 1000 · treating kidney stones

It is very uncertain whether tubeless PNL changes severe adverse events MCID: 50 per 1000 compared with standard PNL (very low certainty).

1 finding from 1 review

Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
RR 1.53 [0.14, 16.46]
2 studies · 46 participants
Very low

Severe adverse events MCID: 50 per 1000 · treating kidney stones

Totally tubeless PNL showed no clear difference in severe adverse events MCID: 50 per 1000 compared with standard PNL (low certainty).

1 finding from 1 review

Totally tubeless, tubeless, and tubed percutaneous nephrolithotomy for treating kidney stones 2023 · Cochrane Headline outcomes only
RR 0.49 [0.19, 1.25]
2 studies · 174 participants
Low